Disease: Prostatic Neoplasms ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms 		0.070 GeneticVariation group LHGDN ABCB1 genetic variation influences the toxicity and clinical outcome of patients with androgen-independent prostate cancer treated with docetaxel. 18628469 2008
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms 		0.070 Biomarker group BEFREE Reactive oxygen species-linked regulation of the multidrug resistance transporter P-glycoprotein in Nox-1 overexpressing prostate tumor spheroids. 16083877 2005
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms 		0.070 AlteredExpression group BEFREE We hypothesize that early in prostate cancer progression, increased expression of YB-1 may increase P-gp activity which may in turn lower androgen levels in the prostate tumor cells. 15042610 2004
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms 		0.070 AlteredExpression group BEFREE Modulation of intrinsic P-glycoprotein expression in multicellular prostate tumor spheroids by cell cycle inhibitors. 11909640 2002
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms 		0.070 AlteredExpression group BEFREE Down-regulation of intrinsic P-glycoprotein expression in multicellular prostate tumor spheroids by reactive oxygen species. 11279018 2001
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms 		0.070 Biomarker group BEFREE Redox regulation of P-glycoprotein-mediated multidrug resistance in multicellular prostate tumor spheroids. 10629088 2000
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms 		0.070 GeneticVariation group BEFREE The MDR1 gene messenger ribonucleic acid (mRNA) was detected in two tumors using the Chinese hamster probe (one sphenoid wing meningioma and one metastatic prostate tumor) and in one CNS lymphoma using the human probe. 1682428 1991